244 related articles for article (PubMed ID: 19318388)
1. Accelerated atherosclerosis in systemic lupus erythematosus: perspectives towards decreasing cardiovascular morbidity and mortality.
Escárcega RO; Garcia-Carrasco M; Jara LJ; Cervera R
Lupus; 2009 Apr; 18(5):383-6. PubMed ID: 19318388
[No Abstract] [Full Text] [Related]
2. [ASA therapy or not?].
Strandberg T; Vanhanen H
Duodecim; 2002; 118(6):557-9. PubMed ID: 12232998
[No Abstract] [Full Text] [Related]
3. Systemic lupus erythematosus and accelerated atherosclerosis.
Hahn BH
N Engl J Med; 2003 Dec; 349(25):2379-80. PubMed ID: 14681501
[No Abstract] [Full Text] [Related]
4. Premature atherosclerosis-related central nervous system involvement in two cases of systemic lupus erythematosus.
Zhang X; Tian X; Zhang F
J Clin Rheumatol; 2007 Aug; 13(4):211-2. PubMed ID: 17762456
[TBL] [Abstract][Full Text] [Related]
5. Should we prescribe statin and aspirin for every diabetic patient? Is it time for a polypill?
Wienbergen H; Senges J; Gitt AK
Diabetes Care; 2008 Feb; 31 Suppl 2():S222-5. PubMed ID: 18227489
[No Abstract] [Full Text] [Related]
6. Cardiovascular disease in lupus patients: should all patients be treated with statins and aspirin?
Bruce IN
Best Pract Res Clin Rheumatol; 2005 Oct; 19(5):823-38. PubMed ID: 16150405
[TBL] [Abstract][Full Text] [Related]
7. [Differentiated treatment of diabetics with an acute coronary syndrome].
Hamm CW; Hamann A
Dtsch Med Wochenschr; 2006 Nov; 131(47 Suppl 7):S208-10. PubMed ID: 17109250
[No Abstract] [Full Text] [Related]
8. Aspirin for the primary prevention of cardiovascular events.
Ferrini R; Clark B
Am Fam Physician; 2002 Nov; 66(9):1737-8. PubMed ID: 12449273
[No Abstract] [Full Text] [Related]
9. Should all patients with systemic lupus erythematosus receive cardioprotection with statins?
Toloza S; Urowitz MB; Gladman DD
Nat Clin Pract Rheumatol; 2007 Oct; 3(10):536-7. PubMed ID: 17700557
[No Abstract] [Full Text] [Related]
10. Serum plant sterols and atherosclerosis: is there a place for statin-ezetimibe combination?
Radermecker RP; Scheen AJ
J Am Coll Cardiol; 2006 Apr; 47(7):1496-7; author reply 1497-8. PubMed ID: 16580546
[No Abstract] [Full Text] [Related]
11. Beta-blockers post-MI reduce progression of coronary atherosclerosis - pooled IVUS trials.
Cardiovasc J Afr; 2007; 18(4):271-2. PubMed ID: 17940676
[No Abstract] [Full Text] [Related]
12. Tumor necrosis factor-alpha as a potential target in the treatment of systemic lupus erythematosus: a role for the HMG-CoA reductase inhibitor simvastatin.
Kotyla PJ; Sliwinska-Kotyla B; Kucharz EJ
J Rheumatol; 2006 Nov; 33(11):2361-3; author reply 2363. PubMed ID: 17086617
[No Abstract] [Full Text] [Related]
13. Acute coronary syndromes. Time to re-think the old paradigm.
Chung EE
West Indian Med J; 2000 Jun; 49(2):93-4. PubMed ID: 10948842
[No Abstract] [Full Text] [Related]
14. LDL-Cholesterol is the King.
Goumas GS
Angiology; 2009; 60(3):387-8. PubMed ID: 19497926
[No Abstract] [Full Text] [Related]
15. Management of ischaemic stroke: statins and antiplatelet agents.
Cimminiello C; Romano A
Neurol Sci; 2005 May; 26 Suppl 1():S24-5. PubMed ID: 15883685
[No Abstract] [Full Text] [Related]
16. Aggressive treatment of atherosclerosis: the time is now.
Fonarow GC
Cleve Clin J Med; 2003 May; 70(5):431-4, 437-8, 440. PubMed ID: 12785316
[TBL] [Abstract][Full Text] [Related]
17. Clinical benefit of early reperfusion therapy in patients with ST-elevation myocardial infarction usually excluded from randomized clinical trials (results from the Maximal Individual Therapy in Acute Myocardial Infarction Plus [MITRA Plus] registry).
Koeth O; Zahn R; Gitt AK; Bauer T; Juenger C; Senges J; Zeymer U;
Am J Cardiol; 2009 Oct; 104(8):1074-7. PubMed ID: 19801027
[TBL] [Abstract][Full Text] [Related]
18. [Assessing the cardiovascular risk in patients with systemic lupus erythematosus].
Arnaud L; Mathian A; Bruckert E; Amoura Z
Rev Med Interne; 2014 Nov; 35(11):723-9. PubMed ID: 25234464
[TBL] [Abstract][Full Text] [Related]
19. Medical therapy versus percutaneous coronary intervention for patients with stable coronary artery disease.
Arbab-Zadeh A
J Am Coll Cardiol; 2009 Feb; 53(6):528-9; author reply 529. PubMed ID: 19195616
[No Abstract] [Full Text] [Related]
20. Vulnerable plaque: scope of the problem.
Wilensky RL
J Interv Cardiol; 2008 Dec; 21(6):443-51. PubMed ID: 18973505
[No Abstract] [Full Text] [Related]
[Next] [New Search]
